Journal
TRANSLATIONAL ONCOLOGY
Volume 1, Issue 3, Pages 148-152Publisher
ELSEVIER SCIENCE INC
DOI: 10.1593/tlo.08142
Keywords
-
Categories
Funding
- National Cancer Institute
- Susan G. Komen for the Cure
- Glenn Foundation for Medical Research
Ask authors/readers for more resources
Telomerase, a ribonucleoprotein important to neoplastic immortality, is up-regulated in approximately 85% of cancers, including leukemias. In this study, 9cUAB30, a novel retinoic acid, resulted in differentiation of HL60 leukemia cells as indicated by morphologic changes characteristic of granulocytes. It also caused a down-regulation of hTERT gene expression and a decrease in telomerase activity. Telomerase inhibition was followed by loss of proliferative capacity, induction of apoptosis, and partial differentiation. These findings demonstrate the effectiveness of 9cUAB30 at inhibiting telomerase activity by down-regulating hTERT gene expression in human leukemic cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available